Cover Image

A STUDY ON PREVALENCE OF METALLOBETALACTAMASE PRODUCING GRAM NEGATIVE BACILLI IN A TERTIARY CARE HOSPITAL

DURDANA PARVEEN

Abstract


Abstract : AIM- To estimate the prevalence of MetalloBeta Lactamase (MBL) producing gram negative bacilli (GNB)   isolated from hospitalized patients and to determine the     Minimum Inhibitory Concentration (MIC) of these isolates to imipenem. MATERIALS AND METHODS- A total of 3204 GNB were isolated from various specimens over a period of 6 months. These isolates were subjected to antimicrobial  susceptibility testing by disc diffusion test as per Clinical and Laboratory Standards Institute(CLSI) guidelines. A total of 1587 isolates which were resistant to ceftazidime were taken up for further study. Modified Hodge Test (MHT) was performed to screen for MBL production by the isolates followed by testing with Combination Disc Test (CDT). Isolates exhibiting an  increase in zone size in CDT were identified as MBL producers. MIC of these MBL producing isolates to imipenem was  determined by macrobroth dilution method as per CLSI  guidelines. Appropriate control strains were used while       performing all the tests. RESULTS- Of the 1587 ceftazidime resistant isolates studied, 1301 were members of  Enterobacteriaceae, 188 were Pseudomonas aeruginosa and 98 were Acinetobacter baumanii. MHT was positive in 78, 26 and 14 of these isolates respectively. However, only 60 of the 78 Enterobacteriaceae, 12 of the 14 A.baumanii and all 26 P.aeruginosa were identified as MBL producers by CDT. Majority of the MBL producing bacilli were isolated from tracheal aspirates. Escherichia coli was the predominant MBL producing member of Enterobacteriaceae. Significant statistical     association was observed between isolates being  non-fermenting bacilli and the production of MBL (p value less than 0.0001). Most of the Enterobacteriaceae isolates exhibited MIC of 16-32 mcg per ml to imipenem while most P.aeruginosa and A.baumanii isolates had MIC of 32-64 mcg per ml. The overall prevalence of MBL production in gram negative bacilli was 3.1 percent with the highest prevalence of 8.5 percent  being observed in P.aeruginosa followed by 6.4 percent in A.baumanii and 2.2 percent in Enterobacteriaceae.   CONCLUSION- The observation of MBL production by various gram negative bacilli emphasizes the need for regular screening of ceftazidime resistant isolates for possible production of MBL. This would help in guiding patient therapy and institute    appropriate infection control measures.

Keyword :Enterobacteriaceae, P.aeruginosa, A.baumanii, MBL, Modified Hodge Test, Combination Disc Test

 


Full Text:

PDF

References


REFERENCES

Chakraborty D, Basu S, Das S. A study on infections caused by gram negative bacilli producing metallobetalactamase in ICU patients. American Journal of Infectious Diseases. 2010; 6:34-9.

Queenan AM, Bush K. Carbapenemases: the versatile -lactamases. Clinical Microbiology Reviews. 2007; 20: 440–58.

Washington Winn Jr, Stephen Allen, William Janda, Elmer Koneman, Gary Procop, Paul Schreckenberger, Gail Woods. Koneman’s Colour Atlas and Textbook of Diagnostic Microbiology, 6th Edition; Chapter 7, pg 303-391.

Bauer A.W, Kirby WMM, Sherris JC and Turck M. Antibiotic Susceptibility by Standardized Single Disc Diffusion Method. American Journal of Clinical Pathology.1966;45: 493-6.

Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement; M100-S17.

Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. Modified Hodge test and EDTA-disk synergy tests to screen metallo-beta- lactamase producing strains of Pseudomonas and Acinetobacter species. Clinical Microbiology and Infections. 2001;7:88–91.

Jesudasan MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase and metallobetalactamase production in clinical isolates. Indian Journal of Medical Research. 2005; 121:780-3.

Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonasaeruginosa producing Metallo-Beta-Lactamases in a large centralized laboratory. Journal of Clinical Microbiology. 2005; 43(3): 129-35.

Franklin C, Liolios L and Peleg A.Y. Phenotypic detection of carbapenem-susceptible metallo-­lactamase-producing gram-negative bacilli in the clinical laboratory. Journal of Clinical Microbiology. 2006; 44: 3139–44.

Ami Varaiya, Manasi Kulkarni, Pallavi Bhalekar, Jyotsana Durga. Incidence of Metallobetalactamase producing Pseudomonas aeruginosa among Diabetes and Cancer patients. Indian Journal of Pathology and Microbiology.2008;51(2): 200-3.

Gupta V, Datta P, Chander J. Prevalence of metallobetalactamase producing Pseudomonas spp and Acinetobacter spp in a tertiary care hospital in India. Journal of Infection. 2006; 52 (5): 311-4.

Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patwardhan NS. Journal of Lab Physicians. 2011; 3(2): 93–7.

G Agarwal, RB Lodhi, UP Kamalakar, RK Khadse, SV Jalgaonkar. Study of Metallo-eta-Lactamase production in clinicalisolates of Pseudomonas aeruginosa.Indian Journal of Medical Microbiology. 2008; 26(4): 349-51.

Navaneeth BV, Sridaran D, Sahay D, Belwadi MR. A preliminary study on metallo-beta­lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian Journal of Medical Research. 2002; 116:264-7.

S.John, Balagurunathan R. Metallobetalactamase producing Pseudomonas aeruginosa and Acinetobacter baumanii. Indian Journal of Medical Microbiology. 2011;29(3): 302-4


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University